Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma

PURPOSE: Systemic therapy has improved rhabdomyosarcoma event-free and overall survival; however, approximately 40 % of patients will have progressive or recurrent disease which is difficult to cure and remains a considerable challenge. Minimal progress has been made in improving outcomes for metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahen, Elliot, Yu, Diana, Harrison, Douglas J., Clark, Justine, Hingorani, Pooja, Cubitt, Christopher L., Reed, Damon R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965487/
https://www.ncbi.nlm.nih.gov/pubmed/27324022
http://dx.doi.org/10.1007/s00280-016-3077-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965487/
https://www.ncbi.nlm.nih.gov/pubmed/27324022
http://dx.doi.org/10.1007/s00280-016-3077-8

Ejemplares similares